Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

66 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Anticancer Properties of a Novel Class of Tetrafluorinated Thalidomide Analogues.
Beedie SL, Peer CJ, Pisle S, Gardner ER, Mahony C, Barnett S, Ambrozak A, Gütschow M, Chau CH, Vargesson N, Figg WD. Beedie SL, et al. Among authors: gardner er. Mol Cancer Ther. 2015 Oct;14(10):2228-37. doi: 10.1158/1535-7163.MCT-15-0320. Epub 2015 Aug 12. Mol Cancer Ther. 2015. PMID: 26269604 Free PMC article.
A phase I trial of the HIV protease inhibitor nelfinavir in adults with solid tumors.
Blumenthal GM, Gills JJ, Ballas MS, Bernstein WB, Komiya T, Dechowdhury R, Morrow B, Root H, Chun G, Helsabeck C, Steinberg SM, LoPiccolo J, Kawabata S, Gardner ER, Figg WD, Dennis PA. Blumenthal GM, et al. Among authors: gardner er. Oncotarget. 2014 Sep 30;5(18):8161-72. doi: 10.18632/oncotarget.2415. Oncotarget. 2014. PMID: 25327558 Free PMC article. Clinical Trial.
Preformulation study of NSC-726796.
Guo D, Cain JP, O'Connell S, Gardner ER, Pisle S, Figg WD, Tabibi SE, Yalkowsky SH. Guo D, et al. Among authors: gardner er. AAPS PharmSciTech. 2012 Jun;13(2):661-73. doi: 10.1208/s12249-012-9784-5. Epub 2012 May 3. AAPS PharmSciTech. 2012. PMID: 22552929 Free PMC article.
Sorafenib is an inhibitor of UGT1A1 but is metabolized by UGT1A9: implications of genetic variants on pharmacokinetics and hyperbilirubinemia.
Peer CJ, Sissung TM, Kim A, Jain L, Woo S, Gardner ER, Kirkland CT, Troutman SM, English BC, Richardson ED, Federspiel J, Venzon D, Dahut W, Kohn E, Kummar S, Yarchoan R, Giaccone G, Widemann B, Figg WD. Peer CJ, et al. Among authors: gardner er. Clin Cancer Res. 2012 Apr 1;18(7):2099-107. doi: 10.1158/1078-0432.CCR-11-2484. Epub 2012 Feb 3. Clin Cancer Res. 2012. PMID: 22307138 Free PMC article.
Population pharmacokinetic analysis of sorafenib in patients with solid tumours.
Jain L, Woo S, Gardner ER, Dahut WL, Kohn EC, Kummar S, Mould DR, Giaccone G, Yarchoan R, Venitz J, Figg WD. Jain L, et al. Among authors: gardner er. Br J Clin Pharmacol. 2011 Aug;72(2):294-305. doi: 10.1111/j.1365-2125.2011.03963.x. Br J Clin Pharmacol. 2011. PMID: 21392074 Free PMC article.
Impact of ABCB1 allelic variants on QTc interval prolongation.
Sissung TM, Gardner ER, Piekarz RL, Howden R, Chen X, Woo S, Franke R, Clark JA, Miller-DeGraff L, Steinberg SM, Venzon D, Liewehr D, Kleeberger SR, Bates SE, Price DK, Rosing DR, Cabell C, Sparreboom A, Figg WD. Sissung TM, et al. Among authors: gardner er. Clin Cancer Res. 2011 Feb 15;17(4):937-46. doi: 10.1158/1078-0432.CCR-10-0925. Epub 2010 Nov 24. Clin Cancer Res. 2011. PMID: 21106724 Free PMC article.
A pharmacodynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancer.
Kelly RJ, Draper D, Chen CC, Robey RW, Figg WD, Piekarz RL, Chen X, Gardner ER, Balis FM, Venkatesan AM, Steinberg SM, Fojo T, Bates SE. Kelly RJ, et al. Among authors: gardner er. Clin Cancer Res. 2011 Feb 1;17(3):569-80. doi: 10.1158/1078-0432.CCR-10-1725. Epub 2010 Nov 16. Clin Cancer Res. 2011. PMID: 21081657 Free PMC article. Clinical Trial.
66 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page